TVGNW Tevogen Bio Holdings Inc. - Warrant
$0,06
Fiyat · Haz 25, 2026
Temel veriler itibarıyla May 15, 2026
52 Haftlık Aralık
$0–$0
96% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
-0.0
ROE
—
Net Kâr Marjı
—
TVGNW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.06
Piyasa Değeri
—
P/E (TTM)
-0.0
EPS (TTM)
$-8.08
Gelir (TTM)
—
Temettü Verimi
—
ROE
—
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
TVGNW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-8.08
2023-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
TVGNW
Akran Ortalaması
P/E (TTM)
-0.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
TVGNW
Akran Ortalaması
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
TVGNW
Akran Ortalaması
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
TVGNW
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
TVGNW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $11M | $31M | $4M | · | |
| SG&A Expense | $15M | $23M | $4M | $953.1K | |
| Operating Expenses | $26M | $54M | $9M | $953.1K | |
| Operating Income | $-26M | $-54M | $-9M | · | |
| Interest Expense | · | $184.0K | $1M | · | |
| Interest Income | · | · | $3M | $5M | |
| Other Non-op | · | · | $2M | $5M | |
| Income Tax | $4.8K | $1.8K | · | · | |
| Net Income | $-26M | $-14M | $-60M | $4M | |
| EPS (Basic) | $-8.08 | $-3.50 | $-2.44 | · | |
| EPS (Diluted) | $-8.08 | $-3.50 | $-2.44 | · | |
| Shares (Basic) | 3,319,812 | 2,933,451 | 24,752,000 | · | |
| Shares (Diluted) | 3,319,812 | 2,933,451 | 24,752,000 | · | |
| EBITDA | · | $-54M | · | · |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $552.4K | $0 | $0 | $129.2K | |
| Prepaid Expense | $828.6K | $919.1K | $670.6K | $145.2K | |
| Current Assets | $2M | $2M | $2M | $274.4K | |
| PP&E (Net) | $170.3K | $296.4K | $458.7K | · | |
| PP&E (Gross) | $584.8K | $721.8K | $721.8K | · | |
| Accum. Depreciation | $414.5K | $425.3K | $263.1K | · | |
| Other Non-current Assets | $1M | $575.8K | $271.1K | · | |
| Total Assets | $4M | $3M | $6M | $357M | |
| Accounts Payable | $3M | $5M | $3M | $210.5K | |
| Accrued Liabilities | $1M | $2M | $1M | · | |
| Short-term Debt | $2M | $2M | · | $0 | |
| Current Liabilities | $7M | $9M | $85M | $350.5K | |
| Capital Leases | $1M | $5.8K | $234.9K | · | |
| Total Liabilities | $13M | $10M | $100M | $15M | |
| Total Debt | · | $2M | · | · | |
| Common Stock | $402 | $356 | $12.0K | · | |
| Paid-in Capital | $123M | $98M | $5M | · | |
| Retained Earnings | $-140M | $-113M | $-100M | $-15M | |
| Stockholders' Equity | $-8M | $-7M | $-94M | $-34M | |
| Liabilities + Equity | $4M | $3M | $6M | $357M | |
| Shares Outstanding | 4,020,746 | 3,559,827 | 119,999,989 | 2,383,053 |
Nakit Akışı 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $16M | $41M | · | · | |
| Operating Cash Flow | $-12M | $-12M | $-8M | $-215.4K | |
| CapEx | $64.4K | · | $133.0K | · | |
| Investing Cash Flow | $-64.4K | · | $-133.0K | · | |
| Stock Repurchased | · | · | $343M | · | |
| Net Stock Activity | · | · | $-343M | · | |
| Financing Cash Flow | $12M | $12M | $4M | · | |
| Net Change in Cash | $-730.6K | $230.6K | $-4M | · |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | · | -306.2% | -0.04% | 1.2% | |
| ROE | · | 213.4% | 0.12% | -29.9% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 0.3 | 0.1 | 0.8 | |
| Quick Ratio | · | 0.0 | 0.0 | 0.4 | |
| Debt / Equity | · | -0.2 | · | · | |
| Interest Coverage | · | -291.1 | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $-195.6K | $-184.0K | · | · | |
| Net Income TTM | $-26M | $-14M | $-60M | $4M | |
| P/E | -0.0 | · | · | · | |
| Earnings Yield | -18198.2% | · | · | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $21M | $908.0K | $1M | $1M | $1M | · | · | · | |
| SG&A Expense | $2M | $3M | $3M | $3M | $7M | $7M | $3M | $4M | $9M | $1M | $1M | $1M | $977.1K | $198.8K | $258.6K | $282.9K | |
| Operating Expenses | $5M | $5M | $6M | $5M | $10M | $9M | $6M | $9M | $30M | $2M | $2M | $2M | $2M | $198.8K | $258.6K | $282.9K | |
| Operating Income | $-5M | $-5M | $-6M | $-5M | $-10M | $-9M | $-6M | $-9M | $-30M | $-2M | $-2M | $-2M | $-2M | · | · | · | |
| Interest Expense | · | · | · | · | $24.6K | · | $12.5K | · | $155.8K | $317.5K | $299.9K | · | $289.0K | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $300.0K | $300.0K | $2M | $2M | $-125.1K | $140.9K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $327.2K | $331.5K | $2M | $2M | $465.6K | $256.9K | |
| Net Income | $-5M | $-5M | $-6M | $-6M | $-10M | $-9M | $-6M | $-10M | $11M | $-4M | $-4M | $-22M | $-31M | $2M | $207.0K | $-26.0K | |
| EPS (Basic) | $-1.61 | $-7.95 | $-0.03 | $-0.03 | $-3.25 | $-3.51 | $-0.03 | $-0.04 | $0.08 | $-1.97 | $-0.03 | $-0.18 | $-0.26 | · | · | · | |
| EPS (Diluted) | $-1.61 | $-7.95 | $-0.03 | $-0.03 | $-3.25 | $-3.17 | $-0.03 | $-0.04 | $-0.26 | $-1.97 | $-0.03 | $-0.18 | $-0.26 | · | · | $0.00 | |
| Shares (Basic) | 3,486,215 | -538,423,264 | 196,028,784 | 184,307,169 | 3,228,142 | -458,741,974 | 170,174,533 | 154,167,090 | 137,333,802 | -335,247,967 | 119,999,989 | 119,999,989 | 119,999,989 | · | · | · | |
| Shares (Diluted) | 3,486,215 | -538,423,264 | 196,028,784 | 184,307,169 | 3,228,142 | -463,795,823 | 170,174,533 | 154,167,090 | 142,387,651 | -335,247,967 | 119,999,989 | 119,999,989 | 119,999,989 | · | · | 35,950,000 | |
| EBITDA | $-5M | · | $-6M | $-5M | $-10M | · | $-6M | $-9M | $-30M | · | · | · | · | · | · | · |
Bilanço 21
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $692.3K | $0 | $1M | $685.2K | $2M | $0 | $2M | $1M | $1M | $0 | $25M | $25M | $52.3K | $143.0K | $185.6K | $231.5K | |
| Prepaid Expense | $1M | $828.6K | $925.8K | $1M | $944.1K | $919.1K | $1M | $1M | $923.2K | $670.6K | $51.9K | $143.3K | $44.8K | $275.4K | $409.1K | $502.6K | |
| Current Assets | $2M | $2M | $2M | $2M | $3M | $2M | $4M | $2M | $2M | $2M | $399.5K | $699.3K | $97.1K | $418.5K | $594.8K | $734.2K | |
| PP&E (Net) | $140.0K | $170.3K | $163.9K | $164.4K | $255.9K | $296.4K | $337.0K | $377.5K | $418.1K | $458.7K | · | · | · | · | · | · | |
| PP&E (Gross) | · | $584.8K | · | · | · | $721.8K | · | · | · | $721.8K | · | · | · | · | · | · | |
| Accum. Depreciation | · | $414.5K | · | · | · | $425.3K | · | · | · | $263.1K | · | · | · | · | · | · | |
| Other Non-current Assets | $1M | $1M | $565.9K | $565.9K | $575.8K | $575.8K | $133.3K | $133.3K | $133.3K | $271.1K | · | · | · | · | · | · | |
| Total Assets | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $6M | $26M | $26M | $25M | $355M | $353M | $353M | |
| Accounts Payable | $4M | $3M | $3M | $4M | $5M | $5M | $6M | $7M | $5M | $3M | $1M | $694.9K | $485.1K | $171.8K | $179.2K | $129.0K | |
| Accrued Liabilities | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | · | · | · | · | · | · | |
| Short-term Debt | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $625.7K | $625.7K | · | · | · | · | |
| Current Liabilities | $7M | $7M | $7M | $8M | $9M | $9M | $10M | $11M | $9M | $85M | $2M | $2M | $667.1K | $281.8K | $259.2K | $179.0K | |
| Capital Leases | $1M | $1M | $1M | $1M | · | $5.8K | $42.6K | $96.8K | $166.8K | $234.9K | · | · | · | · | · | · | |
| Total Liabilities | $15M | $13M | $12M | $14M | $12M | $10M | $10M | $11M | $9M | $100M | $17M | $16M | $15M | $15M | $15M | $15M | |
| Total Debt | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $625.7K | · | · | · | · | · | |
| Common Stock | $417 | $402 | $19.7K | $19.4K | $18.4K | $356 | $17.1K | $16.9K | $16.5K | $12.0K | · | · | · | · | · | · | |
| Paid-in Capital | $126M | $123M | $118M | $111M | $107M | $98M | $91M | $88M | $76M | $5M | · | · | · | · | · | · | |
| Retained Earnings | $-145M | $-140M | $-135M | $-129M | $-124M | $-113M | $-104M | $-98M | $-88M | $-100M | $-16M | $-16M | $-15M | $-15M | $-14M | $-14M | |
| Stockholders' Equity | $-10M | $-8M | $-8M | $-9M | $-8M | $-7M | $-6M | $-8M | $-6M | $-94M | $-16M | $-16M | $-15M | $-15M | $-14M | $-14M | |
| Liabilities + Equity | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $6M | $26M | $26M | $25M | $355M | $353M | $353M | |
| Shares Outstanding | 4,168,705 | 4,020,746 | 197,391,411 | 193,693,433 | 183,893,433 | 3,559,827 | 170,773,864 | 168,826,402 | 164,614,418 | 119,999,989 | · | · | · | · | · | · |
Nakit Akışı 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $3M | $3M | $7M | $7M | $3M | $4M | $26M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-2M | $-2M | $-6M | $-4M | $-2M | $-42.6K | $-45.9K | $-113.0K | |
| CapEx | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $133.0K | · | · | · | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | $0 | $-333M | $-333M | $-133.0K | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $3M | $2M | $4M | $2M | $4M | $2M | $5M | $3M | $2M | $422.2K | $336M | $336M | $2M | · | · | · | |
| Net Change in Cash | $139.9K | $-484.7K | $351.9K | $-1M | $691.9K | $-1M | $1M | $-182.5K | $265.5K | $-2M | $-850.0K | · | · | · | · | · |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 7589.2% | · | 9190.6% | 14315.3% | · | · | · | -143317116.7% | · | · | · | · | · | · | · | · | |
| Net Margin | 7652.9% | · | 9186.4% | 14471.6% | · | · | · | -161057450.0% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 7589.2% | · | 9190.6% | 14315.3% | · | · | · | -143317116.7% | · | · | · | · | · | · | · | · | |
| ROA | -121.1% | · | -130.4% | -145.2% | -278.8% | · | -38.3% | -65.1% | 78.1% | · | -0.15% | · | 0.65% | 0.91% | 0.12% | -0.01% | |
| ROE | 62.0% | · | 81.7% | 64.3% | 153.3% | · | 52.6% | 83.4% | -106.6% | · | 1.8% | · | -8.3% | -22.0% | -2.9% | 0.36% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.2 | 0.3 | · | 0.2 | · | 0.1 | 1.5 | 2.3 | 4.1 | |
| Quick Ratio | 0.1 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 13.7 | · | 0.1 | 0.5 | 0.7 | 1.3 | |
| Debt / Equity | -0.2 | · | -0.2 | -0.2 | -0.2 | · | -0.3 | -0.2 | -0.3 | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | -421.5 | · | -488.4 | · | -189.5 | · | · | · | · | · | · | · |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | -0.0 | · | -0.0 | -0.0 | · | · | · | 0.0 | · | · | · | · | · | · | · | · |
Değerleme (TTM) 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $-196.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-27M | · | $-27M | $-31M | $-15M | · | $-8M | $-24M | $-46M | · | $-55M | $-51M | $-29M | $2M | $169.6K | $-48.7K | |
| Market Cap | $141.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | -0.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | -0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | -5.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -14513.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-26M | $-14M | $-60M | $4M | — |
| Seyreltilmiş Hisse Başı Kâr | $-8.08 | $-3.50 | $-2.44 | — | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | -0.2 | — | — | — |
| Cari Oran | — | 0.3 | 0.1 | 0.8 | 13.3 |
| Cari Oran | — | 0.0 | 0.0 | 0.4 | 5.8 |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.